An interventional study of intensive rehabilitation after uncemented TKA in Knee Osteoarthritis, sponsored by Istituto Ortopedico Rizzoli. Recruiting at 1 site in Italy. Open to participants aged 40 Years to 65 Years. Per ClinicalTrials.gov, last updated 2025-05-18.
Sponsored by Istituto Ortopedico Rizzoli · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 31 studies in Osteoarthritis, Knee by Istituto Ortopedico Rizzoli — 13 open to participants now, 13 under way, none of them phase 3. Osteoarthritis, Knee · Istituto Ortopedico Rizzoli.
Among the 31 studies in Osteoarthritis, Knee by Istituto Ortopedico Rizzoli, this one is the 21st largest by planned enrollment of the 25 interventional ones that give a count, is one of 3 that started in 2025, is one of 21 with no phase, reaches primary completion later than 1 of the 12 other live ones, and was the 24th registered.
3,297 studies on the registry are indexed under Osteoarthritis, Knee; 623 are open to participants now.
Browse Osteoarthritis, Knee studies →13 of the 31 studies in Osteoarthritis, Knee by Istituto Ortopedico Rizzoli are open now, in 1 country. Recruiting first, the newest first:
Istituto Ortopedico Rizzoli · Sites in Italy
Ages 18–60
Istituto Ortopedico Rizzoli · Sites in Italy
Ages 65–80
Istituto Ortopedico Rizzoli · Sites in Italy
Ages 18–85
Istituto Ortopedico Rizzoli · Sites in Italy
Ages 40–75
Istituto Ortopedico Rizzoli · Sites in Italy
Ages 18–40
By country, each count listing its studies:
Of the 384 Osteoarthritis, Knee studies recruiting now, 178 (46%) set no upper age limit and 113 (29%) stop at 75 or younger; 19 take children under 18; 39 take healthy volunteers.
This study: 40 Years to 65 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
31 studies; the count open now beside each. This study's row is marked.
First in 2009; this study’s year is marked. 3 started in 2025.
This study's planned enrollment of 20 is below the median of 68 across 2,719 interventional studies indexed under Osteoarthritis, Knee.
Median enrollment 50 across the 25 interventional studies, 105 across the 6 observational. Of the 18 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
Istituto Ortopedico Rizzoli is the lead sponsor of 305 studies on the registry; 104 are open to participants now.
4 of the studies in Osteoarthritis, Knee by Istituto Ortopedico Rizzoli that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06726629Istituto Ortopedico RizzoliCrosscultural Adaptation And Validation Of The Italian Version Of The New Knee Society Knee Scoring System | 2026-11 |
| NCT06251752Istituto Ortopedico RizzoliLong Term Evaluation of Clinical and Radiologic Results on Femoro-patellar Joint After High Tibial Osteotomy | 2026-12 |
| NCT06040957Istituto Ortopedico RizzoliBone Marrow Versus Adipose Tissue as a Cell Source for Infiltrative Treatment of Knee Osteoarthritis | 2027-01 |
| NCT06490770Istituto Ortopedico RizzoliAnalysis of the Pathophysiological and Functional State of the Knee Joint | 2027-04 |
Add all 4 to your calendar (.ics) → With an account.
Among the 31 studies in Osteoarthritis, Knee by Istituto Ortopedico Rizzoli, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The majority of patients undergoing total knee arthroplasty are elderly individuals with low functional demands, aiming to alleviate pain. However, there exists a subgroup of younger patients, under the age of 65, with higher functional demands. The purpose of this study is to evaluate the return to sports activities in this patient group following a non-cemented total knee arthroplasty procedure and a specific rehabilitation protocol. The investigators expect that with the use of non-cemented prostheses and a specific rehabilitation protocol, many of these patients will safely resume sports activities.
Most of the patients requiring total knee arthroplasty (TKA) suffer from primary geriatric osteoarthritis. These are predominantly elderly women, often overweight. According to the 2020 RIPO report, the average age of patients receiving primary bi- or tri-compartment knee replacement implants is 70.5 years, with 70% being women, 84% suffering from primary osteoarthritis; 40% are overweight, and 42% are obese. Generally, these individuals are frail elderly with almost complete immobility due to arthritis; post-surgery, relieved of pain, these patients typically return to very modest physical activity in terms of duration and intensity.
However, there exists a wholly different subgroup. These are patients aged ≤65 years, often men, who have been engaged in one or more sports activities since youth. Often, due to a sports-related injury, patients present to orthopedic consultation at a much younger age, with a severely arthritic condition, such as from ligamentous or meniscal trauma rendering the knee less stable, yet these patients have continued to load it intensely during sports activities. Literature and registry studies indicate that the incidence of TKA in this ≤65 age group has recently increased and is expected to rise further. Almost all of these patients have an ambitious postoperative recovery expectation, aiming to return to sports practice. This expectation is generally unmet today because the entire clinical pathway is typically designed for the first subgroup described above, the elderly and frail.
With the use of cemented knee prostheses, which remain the most commonly adopted choice worldwide, the overload on the implant leads to an increased incidence of aseptic loosening at the prosthesis-cement interface. This results in poor clinical and functional outcomes in the athletic patient subgroup and an increased failure rate, necessitating prosthetic revision, which is even more invasive and costly. Modern uncemented TKAs involve initial stable implant fixation through a robust press-fit mechanism of the component to bone and additional pegs for added stability. Definitive biological stability is achieved around 12 weeks post-surgery through osseointegration at the prosthesis interface facilitated by highly porous and/or hydroxyapatite-coated component surfaces.
Uncemented TKAs have shown undeniable advantages over the years, including reduced surgical time (with consequent reduction in general and infection-related complications), preservation of bone stock, and greater ease of performing prosthetic revision procedures. Additionally, with next-generation uncemented prostheses, the problem of loosening at the interface has significantly diminished, thanks to the use of biomaterials allowing firm implant fixation over time, enabling a quicker and more efficient patient activity resumption with a lower risk of prosthetic overload damage.
The long-term goal of this project is to explore whether and under what conditions it is possible to envision a return to sports activity for individuals who have undergone TKA. This type of intervention would constitute a form of tertiary prevention, aimed at containing and controlling the complex outcomes of a pathology, in this case, the drastic reduction in quality of life caused by the suspension of sports practice for this population subgroup. The larger the affected population, the more significant the importance of tertiary prevention, and thus the better the final outcome.
Regular physical activity is a well-known protective factor for the prevention and management of non-communicable diseases. According to the latest WHO (World Health Organization) guidelines from 2020, in adults (18-65 years), physical activity confers benefits for several health outcomes, reducing overall mortality, cardiovascular disease mortality, incidence of hypertension, breast and colon cancer, and type 2 diabetes onset. Physical activity also has mental health benefits, delays dementia onset, can contribute to maintaining a healthy weight, and overall well-being. It also helps prevent falls and fall-related injuries, as well as slowing down bone health decline and functional capacity decline.
The aim of our study is to evaluate the clinical and functional outcomes in patients aged 40 to 65 undergoing uncemented TKA with functional alignment and subjected to an intensive rehabilitation protocol aimed at returning to sports activity at the two orthopedic units, "Orthopedic and Traumatological Clinic 1" and "Orthopedics-Traumatology and Prosthetic Surgery and Hip and Knee Reimplantation"
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Procedure: intensive rehabilitation after uncemented TKA
patients undergoing an intensive rehabilitation protocol after uncemented tka
number of patients returning to sports activities assessed by questionnaire
Time frame: 1 year from the surgery
clinical and functional outcomes measured as the variation in the Knee Society Score
Time frame: at 1, 3, 6 and 12 months from the surgery
Started Apr 2025 (actual). Primary completion is estimated for Dec 2025, 8 months after the start.
Of 1,114 non-industry interventional studies with no phase under Osteoarthritis, Knee, half reached primary completion within 18 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 36. This study's planned 8 months is below that.
Counting every sponsor, half of 1,253 studies reached it within 18 months; a quarter within 8 and three quarters within 36.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
No contact was published for this record. The registry link below has the sponsor’s details.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.